Drs. Diane Krause and Stephanie Halene (not pictured) were presented with the @yalecancer.bsky.social Basic Science Research Award for their research identifying new & promising targets for future treatments in patients with acute megakaryoblastic leukemia. #AMKL ashpublications.org/blood/articl...

This new study reveals how C/G fusion drives #EpigeneticReprogramming via #DNMT3B in acute megakaryoblastic #Leukemia (AMKL), highlighting DNMT3B inhibition as a promising #therapeutic avenue for #AMKL. @uamshealth.bsky.social #medsky

#OpenAccess: www.sciencedirect.com/science/arti...

Yale Study: Potential Treatment Pathway Found for Rare and Aggressive Leukemia A Yale study published Aug. 28 on the cover of the journal Blood explains basic scientific discoveries that could lead to innovative therapies for acute myeloid

Research led by Madeline Mayday @yalepathology.bsky.social uncovered how a mutant protein drives rare childhood leukemia #AMKL by hijacking RNA + Wnt signaling. Targeting these pathways with experimental inhibitors suppressed #leukemia growth. yalecancercenter.org/news-article...